SCHEMBL9877955

SCHEMBL9877955

O=c1n(O)ccn1Cc1ccc(-c2ccccc2)cc1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HDAC8 Q9BY41 1/20 0.49
▸ HDAC6 Q9UBN7 1/20 0.49
▸ FAAH O00519 2/20 0.49
▸ MGLL Q99685 2/20 0.49
▸ MMP2 P08253 1/20 0.46
▸ MMP3 P08254 1/20 0.46
▸ MMP9 P14780 1/20 0.46
▸ IDH1 O75874 1/20 0.43
▸ CYP11B1 P15538 2/20 0.43
▸ CYP11B2 P19099 2/20 0.43
▸ CNR2 P34972 1/20 0.42
▸ CHRM1 P11229 3/20 0.42
▸ DAO P14920 1/20 0.42
▸ HTT P42858 2/20 0.42
▸ ABCC4 O15439 1/20 0.42
▸ LMNA P02545 1/20 0.42
▸ GAA P10253 1/20 0.42
▸ TSHR P16473 1/20 0.42
▸ PTGS1 P23219 1/20 0.42
▸ CYP17A1 P05093 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10077158 0.90 KDM4E (0.47) HDAC8HDAC6MGLLHTTLMNA
SCHEMBL9707256 0.80 PTGS1 (0.38) HDAC8HDAC6CNR2CHRM1LMNA
SCHEMBL9876997 0.79 MAPK14 (0.55) HDAC6LMNAPTGS1KDM4EALDH1A1
SCHEMBL27478800 0.76 F2 (0.54) HDAC8HDAC6MGLLHTTLMNA
SCHEMBL9877285 0.73 KDM4E (0.47) FAAHMGLLDAOHTTLMNA
SCHEMBL14328169 0.72 EGLN1 (0.71) HDAC8HDAC6FAAHMGLLMMP2
SCHEMBL9022567 0.70 CNR2 (0.57) HDAC8HDAC6FAAHMGLLMMP2
SCHEMBL4993019 0.70 BRD4 (0.59) HDAC8HDAC6CNR2CHRM1HTT
SCHEMBL9080467 0.69 HTT (0.65) HDAC8HDAC6MMP2MMP3MMP9
SCHEMBL22252623 0.68 TP53 (0.47) HDAC8HDAC6HTTLMNAKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5036157-A Hydroxamic acid derivatives, lipoxygenase and cyclooxygenase inhibitors, anticoagulants, antiinflammatory agents BURROUGHS WELLCOME CO. 1991-07-30 — — US disclosed
US-4977188-A Hydroamic acid derivatives BURROUGHS WELLCOME CO. (US) 1990-12-11 — — US disclosed
WO-1990001929-A1 NEW MEDICAL USE THE WELLCOME FOUNDATION LIMITED (GB) 1990-03-08 — — WO disclosed
US-4738986-A CYCLOOXYGENASE, LIDOXYGENASE INHIBITORS BURROUGHS WELLCOME CO. (US) 1988-04-19 — — US disclosed
EP-0196184-A2 Aryl derivatives THE WELLCOME FOUNDATION LIMITED (GB) 1986-10-01 — — EP disclosed
Send feedback